Get started
Author

Annette Grambihler

Observed names: A GRAMBIHLER, A Grambihler, A. Grambihler, Grambihler, A., Grambihler, Annette
OpenAlex ID: A5086497834
Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression
2003 · Ali Canbay, Ariel E. Feldstein, et al. · Hepatology · 470
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1 /Fas) Mediated apoptosis
1998 · Susanne Strand, Walter J. Hofmann, et al. · Nature Medicine · 278
Mcl-1 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Human Cholangiocarcinoma Cells
2004 · Makiko Taniai, Annette Grambihler, et al. · Cancer Research · 218
Reactive Oxygen Intermediates Are Involved in the Induction of CD95 Ligand mRNA Expression by Cytostatic Drugs in Hepatoma Cells
1997 · Hubert Hug, Susanne Strand, et al. · Journal of Biological Chemistry · 178
Bile Acids Up-regulate Death Receptor 5/TRAIL-receptor 2 Expression via a c-Jun N-terminal Kinase-dependent Pathway Involving Sp1
2003 · Hajime Higuchi, Annette Grambihler, et al. · Journal of Biological Chemistry · 143
PDF
Bile Acids Stimulate cFLIP Phosphorylation Enhancing TRAIL-mediated Apoptosis
2002 · Hajime Higuchi, Jung-Hwan Yoon, et al. · Journal of Biological Chemistry · 114
PDF
cFLIP-L Inhibits p38 MAPK Activation
2003 · Annette Grambihler, Hajime Higuchi, et al. · Journal of Biological Chemistry · 61
PDF
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B
2012 · Jens M. Kittner, Martin F. Sprinzl, et al. · Journal of Clinical Virology · 54
The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease
2016 · Yvonne Alt, Anna Grimm, et al. · PLoS ONE · 32
PDF
Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function
2018 · Frank P. Schmidt, Tim Zimmermann, et al. · International Journal of Cardiology · 31
Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)
2019 · Leonard Kaps, Annette Grambihler, et al. · Digestive Diseases and Sciences · 30
Response to discontinuation of long-term nucleos(t)ide analogue treatment in HBeAg negative patients: Results of the Stop-NUC trial
2020 · Florian van Bömmel, Kerstin Stein, et al. · Journal of Hepatology · 23
Health-related quality of life in patients with autoimmune hepatitis
2021 · Maurice Michel, Francesca Spinelli, et al. · Quality of Life Research · 17
PDF
Hepatitis B virus‐specific T‐cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment
2013 · M. F. Sprinzl, C. Russo, et al. · Journal of Viral Hepatitis · 14
Predictive Scores in Primary Biliary Cirrhosis
2014 · Arndt Weinmann, Thomas Sattler, et al. · Journal of Clinical Gastroenterology · 13
Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents
2013 · Jens M. Kittner, Nora M. Weiss, et al. · Digestive and Liver Disease · 11
Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON study
2018 · M. Sprinzl, A. Grambihler, et al. · Journal of Hepatology · 3
29 Kupffer cell generated death ligands potentiate cholestatic liver injury
2003 · A CANBAY, A FELDSTEIN, et al. · Hepatology · 3
Symptom burden and treatment response in patients with primary biliary cholangitis (PBC)
2020 · L Kaps, A Grambihler, et al. · Zeitschrift für Gastroenterologie · 1
Symptom burden and treatment response in patients with primary biliary cholangitis (PBC) – real life data form Germany
2019 · L Kaps, B Yemane, et al. · Zeitschrift für Gastroenterologie · 1
SAT-067-Prospective assessment of sarcopenia as a prognostic factor for survival in patients with liver cirrhosis
2019 · Wolfgang Maximilian Kremer, Sandra Koch, et al. · Journal of Hepatology · 1
Hepatitis B patients under oral nucleos(t)ide treatment with intermittent kidney function assessment (The BONIKA-study) – a multicenter, prospective, observational trial (NCT-Nr. 02267473)
2017 · K. Sprinzl, S. Steinhoff, et al. · Journal of Hepatology · 1
Add on Interferon-Alpha-2a for the Treatment of HBeAg Negative Hepatitis B Patients Receiving Effective Nucleos(t)ide Therapy: Interim Results of the Prospective Multicentre PADD-On Trial
2016 · M.F. Sprinzl, A. Grambihler, et al. · Journal of Hepatology · 1
Cancer of the Liver and Bile Ducts
2007 · Michael L. Kendrick, Annette Grambihler, et al. · Springer eBooks · 1
Biochemical remission in autoimmune hepatitis determines health-realted quality of life
2020 · M Michel, F Spinelli, et al. · Zeitschrift für Gastroenterologie
Works count: 45
Citation count: 1,699
H-index: 14
I10-index: 16
Year
Topic
Type